11 March 2019
Axial Biotherapeutics Raises $25 Million in Series B Financing
Funds will be used to advance Axial’s gut-targeted programs in Parkinson’s Disease and Autism Spectrum Disorder. Seventure Partners commits new funding from...
Life Sciences
5 March 2019
Health for Life Capital II™, World Leading Microbiome-focused Fund Announces its First Close
Health for Life Capital II™ to focus on the microbiome, and health, nutrition and digital/connected health sectors.
1 March 2019
Seventure Partners Life Sciences Corporate Update September 2018 – February 2019
Seventure Partners, one of Europe’s leaders in financing innovation and a world-leader in the venture investment in the microbiome sector, is pleased to provide an update on...
21 February 2019
BiomX raises $32M series B to bring first two therapies to clinic
Phage therapy company BiomX Ltd. (Ness Ziona, Israel) raised a $32 million series B round on Wednesday, 20th February, that will take its lead candidate, acne therapy BX001,...
20 February 2019
Seventure Keeps up Pace of Its International Microbiome Investments, Closing Four Deals Spanning Seed to Series C
Seventure Keeps up Pace of Its International Microbiome Investments, Closing Four Deals Spanning Seed to Series C
19 February 2019
Vedanta Biosciences Publishes Seminal Research in Leading Scientific Journal for its Immuno-oncology Candidate, VE800
Vedanta Bioscience, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human...
19 February 2019
MycoTechnology, a FoodTech company, has raised $30 million in a Series C funding round
The latest investment will help drive expansion and accelerate research & development to introduce new and novel ingredients to the market.
30 January 2019
MycoTechnology Raises $30 Million in Series C Financing Round with Investments from the Biggest Names in Food
The $30 million in new investment will fuel expansion and accelerate R&D project execution. This funding round opens up an opportunity to explore different ways to meet...
18 January 2019
Cees de Jong: new Chairman of the joint start-up A-Mansia Biotech
A-Mansia Biotech, a microbiome company, has announced the appointment of Cees de Jong as the Chairman of its Board of Directors. His experience of successfully managing several...
20 December 2018
Novartis reimagines neurosciences by developing smart templates that measure progression in MS patients, in collaboration with FeetMe and the Vithas Nisa Foundation
Specialized in smart medical devices, FeetMe focused on the development of portable insoles that measure progression in patients with multiple sclerosis (MS).